A Patient With a Cardiac Mass
In this cardio-oncology broadcast, Prof Dan Lenihan (Saint Francis Healthcare System, US), Prof Joe Carver (University of Pennsylvania, US) and Dr Jeanne DeCara (University of Chicago Medicine, US) are joined by Dr Masood Shekarchizadeh (Isfahan Cardiovascular Research Institute, IR) presenting an intriguing case of a 44-year-old man with a cardiac mass. Following the presentation, the esteemed faculty will engage in a dynamic discussion, delving deep into the complexities of this case and explore the latest research findings and advancements in the field of cardio-oncology, providing a clear view of cutting-edge treatments and emerging therapies. By sharing their expertise, the faculty will unveil the complex interactions between cancer treatments and their potential impact on the cardiovascular system.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
This is an independent activity run by the International Cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by AstraZeneca, BMS/Pfizer Alliance, Eli Lilly and Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
This broadcast is supported by
Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute and the Chief of Staff of the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.
Dr Jeanne DeCara is the founder and director of the Cardio-Oncology programme at University of Chicago Medicine, Chicago, US.
Her practice focuses on diagnosing and treating heart disorders among patients who have received or are about to receive chemotherapy with potential cardiac side effects and/or chest radiation as part of their cancer therapy.
Dr DeCara’s research focus is directed toward the application of noninvasive imaging techniques for the diagnosis and prognosis of patients with clinical and subclinical heart disease. She has expertise in the area of echocardiography, including use of strain for early detection of left ventricular dysfunction in patients receiving potentially cardiotoxic chemotherapy.
She currently serves as President-Elect of the Echocardiography Board of the Intersocietal Accreditation Commission. She has served on the national American College of Cardiology Cardio-Oncology section leadership council and has recently been invited to be a member of the American Heart Association Cardio-Oncology Subcommittee of the Council on Clinical Cardiology.
Dr Masood Shekarchizadeh works within a Cancer Prevention Research Center, Omid Hospital and conducts research at Cardio-Oncology Department, Isfahan Cardiovascular Research Institute, recognised as a WHO Collaborating Center in the Eastern Mediterranean Region (EMR).
His focus lies in diagnosing and treating heart disorders among patients who have received or are about to receive chemotherapy with potential cardiac side effects and/or chest radiation as part of their cancer therapy.